Abstract: An inhalation type medication delivery device includes a dispenser body having a powder containment chamber at one axial side thereof and an inhalation port for drawing in a powder type medication on the another. An attached lid is provided on the dispenser body for opening and/or closing the powder containment chamber. In addition, an air passage is defined in the body allowing a powder type medication to be introduced into an airflow toward the inhalation port according to inhalation by a user. One end of the air passage opens through the lid towards the outside atmosphere and the other end communicates with the inhalation port while passing through the powder containment chamber. Also, a check valve is installed in the lid to prevent air drawn into said inhalation port from flowing in an outward direction opposite a medication delivery direction toward the inhalation port.

Abstract: An inhaling piece 1 is formed with an inhaling mouth 3 and a holder accommodating section 2. A capsule holder 6 is formed with a capsule accommodating hole 7 and air flow passages 8, 8 which extend axially, and is further formed with pin insertion holes 10, 11 which extend diametrically and are in communication with these air flow passages 8. When a capsule 17 is accommodated in the capsule accommodating hole 7 and the pins 16 are inserted into the pin insertion holes 10, 11, through-holes H, H, . . . are formed in the capsule 17. When the patient intends to inhale medicine, inhaling is made by first returning the pins 16 to the inhaling piece 1 so that the medicine can be securely and effectively carried to the lungs of the patient under the action of air flow.

Abstract: An inhaler type medicine administering device comprises a generally cylindrical inhaling piece including a holder accommodating section located at one side of the inhaling piece, and an inhaling mouth located at the other side of the inhaling piece. A generally cylindrical capsule holder is disposed in the holder accommodating section and formed with a capsule accommodating hole which opens at one end of the capsule holder. A capsule is to be disposed in the capsule accommodating hole. First and second pin insertion holes are formed in the capsule holder and the inhaling piece and respectively located to be connected with axially opposite sections of the capsule accommodating hole. Each pin insertion hole extends generally in a diametrical direction of the inhaling piece and the capsule holder. An air flow passage is axially formed at at least one of an inner peripheral surface of the inhaling piece and an outer peripheral surface of the capsule holder.

Abstract: An inhaler type medicine administering device for administering fine granular medicine to the lungs of a patent. The medicine admimistering device comprises a generally cylindrical inhaling piece including a cylindrical holder accommodating section. First and second outside pin insertion holes are formed through the cylindrical wall of the holder accommodating section. A capsule holder is provided to be accommodable within the holder accommodating section of the inhaling piece. The capsule holder is formed with a capsule accommodating hole opened to its end section in which hole a capsule containing medicine is accommodable. First and second inside pin insertion holes are formed extending in the diametrical direction of the capsule holder so as to pass through the capsule accommodating hole. The first inside pin insertion hole is capable of being brought into alignment with the first outside pin insertion hole to form a first pin insertion hole.

Abstract: Disclosed is a novel agent for curing rheumatism, which consists of a pharmaceutical composition containing 5-fluorouracil or an N-derivative thereof to be converted into 5-fluorouracil within the body, which is less in side effects, which has a high degree of safety, and which is high in curing effects.

Abstract: Disclosed is a topical preparation for healing wounds of the skin, which can demonstrate remarkable effects of the treatment of wounds of the skin, such as an ulcer of the skin, traumatogenic wounds caused by the abrasion of the skin, traumatogenic wounds caused by the defect of the skin, an ulcer of the crus, zoster, and so on. The topical preparation contains at least one pharmaceutically effective compound selected from gefarnate, and sofalcone.